Healthcare organizations in the U.S. are starting to use Generative AI technologies more often. About 46% of healthcare groups already use GenAI tools. Nearly all others plan to adopt them within two years. Along with this, investments are rising—around 87% of healthcare groups plan to spend money on AI projects in the next year.
Despite this growth, few consumers are using GenAI for health reasons. A 2024 survey by Deloitte shows that only 37% of consumers used GenAI tools for health in 2024, down from 40% in 2023. This shows patients do not fully trust these tools yet.
Most consumers agree GenAI could help by cutting wait times and lowering health costs. But more people are worried about AI health information. In 2024, 30% of consumers were skeptical, up from 23% last year. This distrust is higher among millennials (30%) and baby boomers (32%). These numbers show healthcare providers need to handle patient doubts and explain AI clearly.
A big challenge with GenAI in healthcare is handling personal health data carefully. U.S. laws and rules demand strict privacy. Healthcare data is very sensitive because patients expect their records to be safe and private. If data is misused or stolen, it can break trust and cause legal problems.
AI systems need large amounts of patient data to learn and work well. This data can include biometrics, images, and electronic health records (EHRs). But there are risks. For example, in 2016, a partnership between DeepMind and the UK’s NHS raised privacy concerns after data was shared without proper consent, hurting public trust.
In the U.S., rules like HIPAA set strict data handling laws. AI needs to process large data beyond what patients initially agreed to sometimes, which makes things harder.
Studies show even anonymous data can be traced back to people using advanced AI. Stanford researchers found AI could re-identify more than 85% of adults and nearly 70% of children in anonymous data. This means old ways to hide data might not work well for AI.
Because of this, healthcare providers must have strong rules for handling data. They need to focus on security, clear information, and letting patients control their data, including saying no or removing it.
Healthcare AI in the U.S. must follow many different and changing rules. Besides HIPAA, laws like California’s CCPA protect personal data in some states. This makes it harder for companies working in many places.
Federal agencies like the FDA are starting to approve AI medical software, like tools for detecting diabetic eye disease. But rules for most AI uses are still in early stages. The White House OSTP released a “Blueprint for an AI Bill of Rights,” which suggests clear patient consent, risk checks, and data limits in AI. These are guides but not law yet.
Some AI systems are hard to understand, called “black box” systems. Even the developers may not fully know how AI makes decisions. This causes problems for explaining AI to patients and regulators, raising questions about who is responsible.
Healthcare groups need clear AI management plans to meet these rules. But studies show only 9% of U.S. healthcare leaders say their groups have strong AI governance. This is a risk and needs quick improvement.
Security threats to healthcare data are growing. AI systems can be attacked. One example is prompt injection, where hackers trick AI to reveal private information. Data theft is also a risk, putting patient details in danger and harming reputations.
AI bias is another problem. When AI learns from data that is not fair or complete, it can treat people unfairly. This can lead to wrong diagnoses or leave out minority groups. These issues raise ethical and legal concerns.
Organizations must do careful risk checks, regular audits, and follow fairness rules when creating and using AI.
GenAI is also changing administrative work in healthcare. This includes front-office phone automation and answering services. Companies like Simbo AI use AI to answer calls, schedule appointments, and respond to questions.
Front-office work handles many phone calls, which can cause delays and unhappy patients. AI can manage calls faster, give correct information, and send patients to the right place without human help for simple tasks.
Simbo AI uses natural language processing to understand callers and reply well, offering help 24/7. This lowers costs and helps staff focus on harder tasks.
But using AI in calls brings privacy and legal concerns. Patient information may be shared during calls, so data must be protected with encryption and follow HIPAA rules. It is important to tell patients when AI is being used. According to Deloitte, 80% of consumers want to know about AI in their care.
Healthcare leaders should choose AI tools that keep data safe and get clear consent from patients. Simbo AI shows how to use GenAI in offices while protecting patient data.
Because of data privacy worries, some healthcare groups use synthetic data to train AI. Synthetic data is made up to look like real data but has no real patient details.
Using synthetic data helps overcome privacy and rule problems. It allows developers to test AI on data that looks like real health records, without risking real information. About 46% of healthcare groups already use or plan to use synthetic data.
Synthetic data helps follow rules by reducing how much real patient data is used. Digital twins, which are virtual copies of patient data, are another method to safely test AI.
But the artificial data must stay good quality and show all groups fairly, or AI results might be biased or less useful.
One way to help GenAI adoption is to get doctors involved. Deloitte reports 74% of consumers trust doctors most for health information. When doctors explain AI tools and their limits, patients trust AI more.
Healthcare leaders should include doctors in AI plans and communication. Doctors can answer patient questions and explain how AI helps but does not replace them.
Being open is important. Patients want to know how AI is used in their care, including how their data is collected and kept safe. Clear, easy-to-understand information helps patients trust and accept AI services.
Thinking about these points carefully will help healthcare organizations use generative AI in ways that respect patient rights, meet laws, and support their work.
Generative AI has the chance to improve healthcare delivery and administration. But in the U.S., making this work means careful care of data privacy, following rules, and building patient trust. Healthcare leaders must balance using new technology with keeping basic privacy and security rules strong to use AI responsibly.
Consumer trust is essential for the successful adoption and utilization of generative AI in healthcare. A lack of trust may lead to decreased engagement and missed opportunities to leverage the technology’s potential benefits, such as improved access and reduced costs.
Healthcare organizations face unique challenges like handling sensitive personal data, regulatory compliance, and the need for accuracy in AI outputs. These challenges can hinder the trust and adoption of generative AI tools.
In 2024, 30% of consumers expressed distrust in AI-generated healthcare information, an increase from 23% in 2023, highlighting growing skepticism among all age groups.
Clinicians can serve as trusted sources of information, educating consumers about the benefits and limitations of generative AI tools, thereby increasing transparency and trust in the technology.
Transparency is crucial for building consumer trust. Consumers want clear information on how generative AI is utilized, including data handling methods and potential limitations associated with the technology.
Involving community partners, such as local health organizations, can leverage existing consumer trust and effectively disseminate accurate information about generative AI, enhancing overall acceptance.
In 2024, only 37% of consumers reported using generative AI for healthcare purposes, which represents a decrease from 40% in 2023, suggesting stagnant adoption rates.
Organizations should revise policies to ensure compliance with regulations concerning patient privacy and provide training that emphasizes both the utility and limitations of generative AI tools.
Consumers expressed a desire for clarity on how generative AI influences their healthcare decisions, including how it enhances diagnosis and treatment options, with 80% wanting this information.
Incorporating generative AI into medical curricula can equip future clinicians to understand its applications, recognize biases, and advocate for responsible use, ultimately enhancing patient care outcomes.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
